Project Grant R01TW013193
- Federal Grant Award Summary Hanoi Medical University received a $166,535 Project Grant from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), awarded March 1, 2026, with completion scheduled for February 29, 2028. The grant funds the adaptation and pilot testing of Project YES+, an evidence-based intervention combining peer mentoring and group-based mental health programming, to create "Tô Hiểu" (I Understand)—a...
- Federal Grant Award Summary The Fogarty International Center (FIC) awarded a $1.26 million Project Grant to the University of California, Los Angeles (UCLA) under the International Research and Research Training program (CFDA 93.989) to develop and evaluate a culturally adapted intervention addressing HIV-related stigma and treatment disengagement among treatment-naïve Indonesian people living with HIV (PLH). The award, dated August 20, 2025, with completion by July 31, 2028, supports UCLA's...
- Federal Grant Award Summary The Johns Hopkins University received a $431,804 Project Grant from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) awarded September 15, 2025, with completion anticipated by June 30, 2028. This award supports the adaptation and assessment of a multi-level stigma mitigation intervention package designed to improve antiretroviral therapy (ART) adherence and viral suppression among women living with HIV (WLHIV) across the...
- Federal Project Grant Award Summary The Fogarty International Center (FIC) awarded Impact Research and Development Organisation (IRDO) a $234,292 Project Grant under the International Research and Research Training program (CFDA 93.989) on September 13, 2025, to develop and pilot test a multilevel, community-based intervention designed to reduce Pre-Exposure Prophylaxis (PrEP) stigma and increase PrEP uptake among adolescent girls and young women (AGYW) ages 15-24 in Western Kenya. The award,...
- Federal Grant Award Summary The University of Pittsburgh received a $188,995 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded August 15, 2025, with a completion date of July 31, 2028. The "Prescribe to Prevent HIV" (P2PH) trial will develop and pilot test an implementation strategy bundle designed to increase access to two evidence-based harm reduction interventions—sterile injection equipment and daily...
- Federal Project Grant Award Summary Yale University received a $217,539 Project Grant from the Fogarty International Center (CFDA 93.989: International Research and Research Training) for a three-year project (April 1, 2026 – March 31, 2029) addressing HIV-related stigma among men who have sex with men (MSM) in Peru. The research deliverables include the development of a tailored same-day antiretroviral therapy (SD-ART) protocol utilizing asynchronous online focus groups and flowcharting...
- Federal Grant Award Summary Columbia University's Sponsored Projects Administration Division received a $670,856 Project Grant from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), awarded September 22, 2025, with completion targeted for August 31, 2028. This initiative will develop and implement a standardized patient (SP) approach to objectively measure negative attitudes toward people with HIV (PWH) and people with...
- Federal Grant Award Summary The National Institute of Mental Health awarded The Johns Hopkins University a $733,314 Project Grant (CFDA 93.242 – Mental Health Research Grants) effective September 23, 2025, through August 31, 2030, to optimize measurement and evaluation of stigma's health impacts among populations at risk for and living with HIV (PLHIV). The project will leverage the PLHIV Stigma Index 2.0 platform—which has previously collected stigma data from over 40,000 PLHIV across 32...
- Federal Grant Award Summary Florida State University received a $616,600 Project Grant from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), effective March 1, 2026, through February 28, 2029. The grant funds the adaptation and pilot testing of the "Healthy Choices" intervention—a four-session behavior change communication program designed to reduce stigma and improve self-management of alcohol use and HIV among...
- Federal Grant Award Summary The University of Pittsburgh received a $437,250 Project Grant award dated August 15, 2025, under the Trans-NIH Research Support program (CFDA 93.310) from the National Institutes of Health Office of the Director. This R21 award will support research investigating the role of CD4 T helper 1 (TH1) cells and T central memory (TCM) cells in driving neuroinflammation associated with HIV-associated neurocognitive disorders (HAND). The research will be conducted through...
The University of Pittsburgh has received a $206,326 Project Grant from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), effective April 1, 2026 through March 31, 2029. The award funds the development and implementation of the DONGHANH intervention, a culturally adapted stigma-reduction program designed for men who have sex with men (MSM) and healthcare providers in Vietnam. The project will culturally adapt the evidence-based FRESH (Finding Respect and Ending Stigma around HIV) intervention using the ADAPT-ITT framework, incorporating qualitative research findings from in-depth interviews and focus group discussions to create a locally tailored version. Deliverables include workshop-based stigma-reduction training materials, an e-learning module (website) for convenient participant access and ongoing learning, and collaborative community-based stigma reduction strategies developed by participants for implementation in their respective communities. The three-phase project directly addresses the rising HIV prevalence among Vietnamese MSM (increasing from 6.6% in 2015 to 12.5% in 2023) by targeting persistent intersectional stigmatization that has created barriers to healthcare access and HIV prevention services. Phase I focuses on intervention adaptation; Phase II will employ a randomized controlled design to evaluate intervention efficacy. Through this work, the University of Pittsburgh will deliver a sustainable, culturally appropriate intervention package that strengthens the capacity of both healthcare providers and affected communities to reduce stigma and improve health outcomes for vulnerable populations in a low- and middle-income country setting.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $46.4k | 2/19/26 | ||
| Not listed | $159.9k | 2/13/26 |